Suministro de medicamentos exclusivos: abatacept (Orencia), golimumab (Simponi), certolizumab pegol (Cimzia), tocilizumab (Roactemra), sarilumab (Kevzara), baricitinib. Prórroga: P.N.S.P. 15/2019

Contract type	Supplies
CPV	33600000
Awarded to	Bristol Myers Squibb, S. A. U.

Full tender details, bidder list, market context and related contracts available below. Data sourced from TED — the Official Journal of the EU.